Last Updated On 7/20/2025 5:41:36 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Pear Bio |
| Recipient: You |
| Company: Phoenix Molecular Designs |
| Recipient: You |
|
| Honoraria |
| Company: Kyowa Hakko Kirin |
| Recipient: You |
| Company: Chugai/Roche |
| Recipient: You |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Medsir |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Genomic Health |
| Recipient: You |
| Company: Medscape |
| Recipient: You |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: You |
| Company: AstraZeneca/UK |
| Recipient: You |
| Company: AstraZeneca/Middle East |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: Carna Biosciences |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Anheart Therapeutics |
| Recipient: You |
| Company: Bristol-Myers Squibb/Celgene |
| Recipient: You |
| Company: Lilly |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Telix Pharmaceuticals |
| Recipient: You |
| Company: Exact Sciences |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Daiichi Sankyo |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|